Jonathan Robert Hunt

CIK: 0001375410

Transaction Breakdown

Open Market Buys (P)5 (71.4%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CATX

Perspective Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

CATX
Perspective Therapeutics, Inc.
Mar 2, 2026
Award(A)
Stock option (right to buy)
Direct
90K shares-
CATX
Perspective Therapeutics, Inc.
Nov 13, 2025
Purchase(P)
Direct
11K shares at avg. $2.03$22K
CATX
Perspective Therapeutics, Inc.
Mar 3, 2025
Award(A)
Stock option (right to buy)
Direct
75K shares-
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Direct
10K shares at avg. $3.88$39K
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Direct
2.4K shares at avg. $3.60$9K
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Direct
400 shares at avg. $3.55$1K
CATX
Perspective Therapeutics, Inc.
Nov 25, 2024
Purchase(P)
Direct
29 shares at avg. $3.94$114.26

		Type	Shares	Price		Ownership
Mar 2, 2026	CATX Perspective Therapeutics, Inc.	Award(A) Stock option (right to buy)	90,000	-	-	Direct
Nov 13, 2025	CATX Perspective Therapeutics, Inc.	Purchase(P)	11,000	$2.03	$22,295	Direct
Mar 3, 2025	CATX Perspective Therapeutics, Inc.	Award(A) Stock option (right to buy)	75,000	-	-	Direct
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	10,000	$3.88	$38,800	Direct
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	2,400	$3.60	$8,640	Direct
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	400	$3.55	$1,420	Direct
Nov 25, 2024	CATX Perspective Therapeutics, Inc.	Purchase(P)	29	$3.94	$114	Direct

1-7 of 7 transactions

About Hunt Jonathan Robert

Hunt Jonathan Robert (SEC CIK 0001375410) files insider reports with the SEC as Chief Accounting Officer of Perspective Therapeutics, Inc. (CATX).

Signal8 holds 4 ownership filings by Hunt Jonathan Robert, all Form 4s, filed between Nov 27, 2024 and Mar 4, 2026. Those filings report 7 transactions, from Nov 25, 2024 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hunt Jonathan Robert's filings is in SEATTLE, WA.

Recent filings by Hunt Jonathan Robert

Mar 2, 2026: Grant or award of CATX derivative securities (Form 4, code A).
Nov 13, 2025: Open-market purchase of CATX shares (Form 4, code P).
Mar 3, 2025: Grant or award of CATX derivative securities (Form 4, code A).
Nov 25, 2024: Open-market purchases of CATX shares (4 lines, Form 4, code P).

Other insiders filing for Perspective Therapeutics, Inc. (CATX)

How to read Form 4 transaction codes